CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the potential of stem cells to replace pancreatic beta-cells for treating Type 1 diabetes. It focuses on the isolation and differentiation of human amniotic fluid stem cells into insulin-producing cells while addressing challenges like immunogenicity and tumor formation.
The use of stem cells for curing disease and ending disabilities may change the medical treatment in this century.
However, there are some major roadblocks that need to be resolved before these cells are implemented in ordinary medical care.
There are serious ethical issues regarding the use of embryonic stem cells, reliable methods for isolation and expansion of stem cells need to be established, stem cell plasticity raises the issue of tumorigenicity, the use of stem cell transplantation might…
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
